SC1
CAS No. 839707-37-8
SC1( Pluripotin )
Catalog No. M16118 CAS No. 839707-37-8
Pluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 68 | In Stock |
|
| 2MG | 41 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 81 | In Stock |
|
| 25MG | 143 | In Stock |
|
| 50MG | 215 | In Stock |
|
| 100MG | 343 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSC1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.
-
DescriptionPluripotin (SC1) is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and RasGAP. Maintains embryonic stem cell (ESC) self-renewal.(In Vitro):Pluripotin (SC-1) inhibits Abl1, p70S6K, PLK2, RSK1, RSK2, RSK3, RSK4 with IC50s of 0.005, 1.4, 2.2, 0.5, 2.5, 3.3, 10.0 μM,respectively. Pluripotin (SC-1) decreases cell growth for 7 colon tumor cell lines. After a five day exposure to 0.1 μM SC-1, the seven colon tumor lines are evaluated for changes in cell number and viability. There is a statistically significant decrease in cell number but >95% viability.
-
In VitroPluripotin (SC-1) inhibits Abl1, p70S6K, PLK2, RSK1, RSK2, RSK3, RSK4 with IC50s of 0.005, 1.4, 2.2, 0.5, 2.5, 3.3, 10.0 μM,respectively. Pluripotin (SC-1) decreases cell growth for 7 colon tumor cell lines. After a five day exposure to 0.1 μM SC-1, the seven colon tumor lines are evaluated for changes in cell number and viability. There is a statistically significant decrease in cell number but >95% viability.
-
In Vivo——
-
SynonymsPluripotin
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK1| RasGAP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number839707-37-8
-
Formula Weight550.53
-
Molecular FormulaC27H25F3N8O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: <1 mg/mL; DMSO: 100 mg/mL (181.64 mM) Water: <1 mg/mL
-
SMILESO=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC(C)=NN4C)N=C3N(C)C2=O)=C1)C5=CC=CC(C(F)(F)F)=C5
-
Chemical NameN-[3-[7-(2,5-Dimethyl-2H-pyrazol-3-ylamino)-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl]-4-methylphenyl]-3-trifluoromethyl-benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen S, et al. Proc natl Acad Sci U S A. 2006 Nov 14;103(46):17266-71.
molnova catalog
related products
-
AX-15836
A potent, highly selective ERK5 inhibitor with IC50 of 8 nM; shows little affinity for BRD4 (Kd=3.6 uM).
-
ISRIB
ISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM.
-
Asperulosidic acid
Asperulosidic acid has anti-tumor, anti-oxidant, and anti-inflammatory activities.ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways.
Cart
sales@molnova.com